small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (458)
  • Capabilities (84)
  • Experience (387)
  • Insights & News (2,637)
  • Other Results (79)

Professionals 458 results

David A. Sakowitz
David A. Sakowitz
Partner
  • New York, 
  • London
Email
+1 212-294-2639
vCard

Partner

  • New York
  • London
Michael J. Blankenship
Michael J. Blankenship
Partner
  • Houston, 
  • San Francisco , 
  • New York
Email
+1 713-651-2678
vCard

Partner

  • Houston
  • San Francisco
  • New York
Michael Wu
Michael Wu
Partner
  • San Francisco , 
  • Los Angeles
Email
+1 415-591-6818
vCard

Partner

  • San Francisco
  • Los Angeles
View All Professionals

Capabilities 84 results

Practice Area

Capital Markets

Our capital markets and securities attorneys represent U.S. and international issuers, institutional investors, underwriters, and placement agents in a wide variety of public and private offerings of debt and equity securities....Read more

Practice Area

Venture Capital

Winston & Strawn serves as the primary legal counsel to more than 200 venture capital fund managers. As we have one of the most active venture capital fund practices among major law firms, we are uniquely positioned to understand the latest market trends for venture capital funds, which allows us to advise our clients on terms that are market for their respective fund(s)’ size, type, and vintage, as well as market terms for agreements entered into in connection with our clients’ businesses and investments. A large and growing client base gives us the opportunity to work on a wide range of funds and transactions and has enabled us to build a team of legal professionals with deep knowledge of the venture capital industry.   ...Read more

Practice Area

Private Equity

Winston & Strawn’s private equity attorneys provide strategic advice and legal counsel to middle-market private equity funds, hedge funds, family offices, real estate funds, alternative asset managers, portfolio companies, and institutional investors. We have one of the broadest and most active national middle-market private equity practices in the U.S. ...Read more

Experience 387 results

Experience

|

January 19, 2026

Winston Advises smartTrade Technologies Group on the Acquisition of kACE

A cross-border team from advised smartTrade Technologies Group (“smartTrade”), a leading provider of multi-asset electronic trading and payments solutions, on its acquisition of kACE Financial (“kACE”), formerly known as Fenics, a well-established provider of technology solutions for FX and interest rate derivatives pricing, analytics, and workflow management....Read more

Experience

|

January 6, 2026

Brightwood Capital’s Acquisition of Museum of Illusions Group

A team led by Bradley Vaiana and Austin Leach represented Brightwood Capital Advisors, LLC (“Brightwood”), a New York–based investment firm, in its acquisition of Museum of Illusions Group, the world’s largest privately held chain of museums, from Invera Capital Partners. As part of the transaction, five previously franchised locations will transition from the chain’s largest franchisee, LOL Entertainment, to become corporate-owned sites. Winston attorneys across multiple practice areas and offices, including M&A, Tax, Intellectual Property, Employee Benefits, and the firm’s UK office, assisted in structuring a complex cross-border transaction to support Brightwood's fund investment goals. The acquisitions were completed on January 6, 2026....Read more

Experience

|

December 15, 2025

Winston & Strawn LLP represented Apogem in the closing of a single-asset continuation vehicle for Lion Beverages, LLC.

Winston & Strawn LLP represented Apogem in the closing of a single-asset continuation vehicle for Lion Beverages, LLC. The transaction, led by Apogem and including J.P. Morgan Asset Management, RCP Advisors, and Montana Capital Partners, raised over $150 million, with significant participation from Encore Consumer Capital. The meaningful GP commitment underscores both confidence in Lion and alignment with investors....Read more
View All Experience

Insights & News 2,637 results

Webinar

|

FEBRUARY 4 – MARCH 11, 2026

Digital Assets: What Financial Institutions Are Building Now… and Next

Spurred by a rapidly evolving regulatory environment and increased commercial demand, financial institutions are accelerating their implementation of blockchain technology and digital assets into their legacy platforms or partnering with digital assets firms to provide their clients with access to crypto markets....Read more

Benefits Blast

|

February 2, 2026

|

3 Min Read

U.S. Department of Labor AMICUS Briefs Support Curbing Wave of ERISA Litigation

An ERISA litigation trend has emerged that would have been unthinkable a few years ago: The U.S. Department of Labor (DOL) is intervening in court and taking the employer’s side. This trend reflects a deliberate policy shift that matters for every plan sponsor and fiduciary in an environment where “regulation by litigation” has become a default strategy for plaintiffs’ lawyers.

Press Release

|

January 30, 2026

|

2 Min Read

Winston & Strawn and Taylor Wessing UK Partnerships Resoundingly Approve Combination

Transatlantic powerhouse Winston Taylor expected to launch in May ...Read more
View All Insights & News

Other Results 79 results

Law Glossary

What Is Consumer Marketing Law?

Consumer marketing law is a broad legal segment dealing with federal and state statutes, along with government regulations, established to ensure that marketing and advertising are truthful. Federal law states that no form of advertising, including online advertising, can be deceptive. Marketing claims must also be evidence-based....Read more

Site Content

What Is Capitalization in Business?

Capitalization is the total amount of a company’s outstanding securities, including short-term debt, long-term debt, and equity securities....Read more

Law Glossary

What Statutes and Regulations Govern the Approval and Marketing of Biosimilars?

Congress passed the Biologics Price Competition and Innovation Act of 2009 (BPCIA) in 2010 an amendment of the Public Health Services Act. The BPCIA is codified at 42 U.S.C. § 262....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2026. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising